Modern Radiation Therapy for Extranodal Nasal-Type NK/T-cell Lymphoma: Risk-Adapted Therapy, Target Volume, and Dose Guidelines from the International Lymphoma Radiation Oncology Group
Clinical guideline published by International Lymphoma Radiation Oncology Group (ILROG) on
The International Lymphoma Radiation Oncology Group (ILROG) is dedicated to enhancing patient outcomes in hematologic malignancies by integrating high-quality radiation therapy in lymphoma management. Based in New York, ILROG aims to facilitate collaboration among lymphoma professionals and improve access to evidence-based care.